Thomas A Albini Selected Research

brolucizumab

1/2022	Safety Outcomes of Brolucizumab in Neovascular Age-Related Macular Degeneration: Results From the IRIS Registry and Komodo Healthcare Map.
1/2022	Clinical Characteristics and Outcomes of Eyes with Intraocular Inflammation after Brolucizumab: Post Hoc Analysis of HAWK and HARRIER.
5/2021	Drug-related adverse effects of antivascular endothelial growth factor agents.
1/2021	Risk of Inflammation, Retinal Vasculitis, and Retinal Occlusion-Related Events with Brolucizumab: Post Hoc Review of HAWK and HARRIER.
12/2020	Brolucizumab-related retinal vasculitis with exacerbation following ranibizumab retreatment: A clinicopathologic case study.
10/2020	Retinal Vasculitis and Intraocular Inflammation after Intravitreal Injection of Brolucizumab.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Thomas A Albini Research Topics

Disease

14	Uveitis 03/2022 - 10/2008
14	Retinal Detachment (Retinal Detachments) 01/2021 - 09/2005
13	Macular Degeneration (Age-Related Maculopathy) 01/2022 - 01/2008
13	Endophthalmitis (Ophthalmia) 01/2021 - 05/2007
12	Inflammation (Inflammations) 01/2022 - 09/2009
9	Macular Edema 01/2020 - 03/2006
9	Cataract (Cataracts) 01/2020 - 01/2006
8	Retinal Vasculitis 01/2022 - 01/2008
8	Infections 10/2020 - 09/2009
4	Tuberculosis (Tuberculoses) 03/2022 - 09/2009
4	Scleritis (Episcleritis) 01/2018 - 10/2005
4	Retinopathy of Prematurity (Retrolental Fibroplasia) 09/2006 - 09/2005
3	Retinal Diseases 05/2021 - 09/2012
3	Glaucoma 01/2018 - 01/2016
3	Retinal Perforations 01/2018 - 01/2013
3	Ischemia 01/2017 - 01/2011
2	Vasculitis (Vasculitides) 12/2021 - 12/2020
2	Vascular Diseases (Vascular Disease) 05/2021 - 11/2010
2	Choroidal Neovascularization 01/2020 - 01/2008
2	Choroidal Effusions 01/2020 - 11/2016
2	Blindness (Hysterical Blindness) 01/2020 - 07/2014
2	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2019 - 01/2016
2	Retinal Vein Occlusion 01/2019 - 01/2014
2	Lymphoma (Lymphomas) 01/2018 - 03/2015
2	White Dot Syndromes 01/2017 - 12/2016
2	Choroid Diseases 12/2015 - 11/2010
2	Blister (Bulla) 11/2014 - 04/2014
2	Necrosis 01/2007 - 10/2005
1	Embolism (Embolus) 03/2021
1	Arterial Occlusive Diseases (Arterial Occlusive Disease) 01/2021
1	Photophobia (Light Sensitivity) 12/2020
1	Delayed Hypersensitivity (Hypersensitivity, Type IV) 12/2020
1	Pain (Aches) 12/2020
1	Conjunctivitis 10/2020
1	COVID-19 10/2020
1	Hyphema 06/2020
1	Rupture 01/2020
1	Autoimmune Diseases (Autoimmune Disease) 11/2019
1	Panuveitis 06/2019
1	Wounds and Injuries (Trauma) 01/2018
1	Lens Subluxation 01/2017
1	Ocular Hypertension (Glaucoma, Suspect) 01/2017
1	Vitreous Hemorrhage 01/2017
1	Air Embolism (Gas Embolism) 11/2016
1	Proliferative Vitreoretinopathy 01/2016
1	Retinal Telangiectasis 12/2015
1	Familial Exudative Vitreoretinopathies 12/2015
1	Erythema elevatum diutinum 07/2015

Drug/Important Bio-Agent (IBA)

12	Retinaldehyde (Retinal)IBA 01/2022 - 11/2010
8	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2021 - 01/2011
7	SteroidsIBA 03/2022 - 01/2008
6	brolucizumabIBA 01/2022 - 10/2020
6	Anti-Bacterial Agents (Antibiotics)IBA 01/2018 - 08/2013
5	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020 - 10/2005
4	Fluorescein (Funduscein)FDA LinkGeneric 01/2021 - 03/2006
4	Pharmaceutical PreparationsIBA 01/2021 - 11/2010
4	Ranibizumab (Lucentis)FDA Link 12/2020 - 04/2011
3	Endothelial Growth FactorsIBA 01/2022 - 04/2011
3	Indocyanine Green (Cardio-Green)FDA LinkGeneric 01/2017 - 07/2015
3	Bevacizumab (Avastin)FDA Link 12/2015 - 11/2010
2	Proteins (Proteins, Gene)FDA Link 03/2022 - 09/2012
2	Methotrexate (Mexate)FDA LinkGeneric 12/2021 - 01/2007
2	Capsules (Microcapsules)IBA 06/2020 - 01/2018
2	Triamcinolone (Aristocort)FDA Link 01/2020 - 10/2005
2	Biological ProductsIBA 11/2019 - 09/2012
2	Vancomycin FDA LinkGeneric 04/2016 - 07/2015
2	AcidsIBA 04/2013 - 09/2009
1	Mydriatics (Cycloplegics)IBA 03/2022
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 12/2021
1	afliberceptIBA 01/2021
1	RNA (Ribonucleic Acid)IBA 10/2020
1	SuspensionsIBA 01/2020
1	Triamcinolone Acetonide (Azmacort)FDA LinkGeneric 01/2020
1	Immunosuppressive Agents (Immunosuppressants)IBA 11/2019
1	Antiviral Agents (Antivirals)IBA 06/2019
1	Methicillin (Metin)FDA Link 01/2018
1	FluorocarbonsIBA 01/2018
1	Coloring Agents (Dyes)IBA 01/2017

Therapy/Procedure

16	Vitrectomy 03/2021 - 09/2005
10	Therapeutics 01/2020 - 10/2005
8	Intravitreal Injections 10/2020 - 04/2011
5	Injections 01/2020 - 04/2011
5	Penetrating Keratoplasty 01/2018 - 07/2014
3	Aftercare (After-Treatment) 12/2021 - 01/2008
2	Stem Cell Transplantation 01/2020 - 01/2016
2	Intraocular Lenses (Intraocular Lens) 01/2016 - 03/2010
2	Lasers (Laser) 04/2015 - 02/2014
2	Photochemotherapy (Photodynamic Therapy) 02/2014 - 01/2008
1	Scleral Buckling 01/2021
1	Retreatment 12/2020
1	Debridement 01/2018
1	Sutures (Suture) 01/2018
1	Cryotherapy (Therapy, Cold) 01/2018
1	Vitreoretinal Surgery 01/2018
1	Trabeculectomy (Trabeculoplasty) 05/2017
1	Operative Surgical Procedures 05/2017
1	Traction 01/2017
1	Compressed Air 11/2016
1	Cannula 11/2016
1	Glaucoma Drainage Implants 01/2016